Michael Mahoney vs D. Keith Grossman

Michael Mahoney

CEO of Boston Scientific

BIO: Mr. Michael F. Mahoney, also known as Mike, has been the Chief Executive Officer of Boston Scientific Corporation since November 1, 2012 and has been its President since October 17, 2011. At Boston Scientific Corporation, Mr. Mahoney is responsible for Boston Scientific's Cardiac Rhythm Management (CRM) and Endoscopy (GI and Pulmonary) businesses, as well as certain corporate functions. He joined Boston Scientific in October 2011, having established a track record of more than 22 years of healthcare experience in building market leading global businesses in medical devices, capital equipment and healthcare IT service businesses at best-in-class companies. Prior to joining Boston Scientific, he served as Worldwide Chairman of Medical Device and Diagnostics Group (MD&D) at Johnson & Johnson from January 3, 2011 to September 2011. He served as a Group Chairman, DePuy Franchise of Johnson & Johnson from April 2007 to January 3, 2011. In this role, he successfully drove a growth strategy via product innovation, multiple acquisitions and International expansion, particularly in China and India. Prior to joining Johnson & Johnson, Mr. Mahoney served as the President and Chief Executive Officer of Global Healthcare Exchange (GHX) from January 2001 to March 2007. He built Global Healthcare Exchange through organic development and strategic acquisitions, successfully integrating seven acquisitions and expanding the business into Europe and Canada. He built his early career at General Electric Medical Systems, where he spent 12 years, in a variety of advancing leadership roles for domestic and global businesses in CT, MRI, X-ray, Healthcare IT and Nuclear Medicine, culminating in the role of General Manager of the Healthcare Information Technology business. He has been Chairman of Boston Scientific Corporation since May 3, 2016. He has been a Director of Boston Scientific Corporation since November 1, 2012. He serves as a Director of BridgePoint Medical, Inc. He has been Independent Director of Baxter International Inc. since October 21, 2015. Mr. Mahoney holds a B.B.A. in Finance from the University of Iowa and an M.B.A. from Wake Forest University.

D. Keith Grossman

CEO of Nevro

BIO: Keith Grossman has over 30 years of experience in the medical device field. Grossman served most recently, and for the second time, as the President, Chief Executive Officer and director of Thoratec Corporation, leading up to its 2015 sale to St. Jude Medical. Prior to Thoratec, he served as President, Chief Executive Officer and director of Conceptus, a women’s health medical device company, leading up to its sale to Bayer Healthcare. Prior to Conceptus, Mr. Grossman served as managing director of TPG (Texas Pacific Group), a private equity firm, as a member of its healthcare investment team. Prior to TPG, Mr. Grossman served as Thoratec’s President, Chief Executive Officer and director for the first ten years of its growth as a commercial company. Mr. Grossman currently serves as Chairman of the Board of Outset Medical, Inc. (privately held), Board member of ViewRay, Inc. and previously served as a member of the Board of directors of Intuitive Surgical, Inc., Kyphon, Inc., and a number of privately held medical device companies. Mr. Grossman received a B.S. in life sciences from The Ohio State University and an M.B.A. from Pepperdine University